Ann: Letter to Shareholders, page-6

These two trials build on previous studies with
BIT225 for treatment of HIV. Once again BIT225 was
found to have statistically significant impact on
important immune and inflammation biomarkers.

These positive results are important as they provide
further evidence that BIT225 is acting in a unique
way against HIV.

Current anti-HIV drugs (also known as antiretroviral
treatment or ART) have come a long way since the
early days of AIDS. However, while ART is generally
very effective at stopping replication of the virus,
these existing drugs have no impact on reservoirs of
HIV that are laid down early in infection and cannot
be cleared out with ART.

Did we see any such changes?
Yes – statistically significant changes were seen in
several immune biomarkers during the 12 weeks on
BIT225/ART treatment compared to before starting
on BIT225 i.e. when on ART alone.

This Technology has value ,,,, the question is can this current Management Team locate the Treatments Optimum Customer? NZT